Corient Private Wealth LLC Has $767,000 Position in Option Care Health, Inc. (NASDAQ:OPCH)

Corient Private Wealth LLC lowered its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 18.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 33,061 shares of the company's stock after selling 7,527 shares during the period. Corient Private Wealth LLC's holdings in Option Care Health were worth $767,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. UMB Bank n.a. grew its stake in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after buying an additional 346 shares during the last quarter. Quarry LP boosted its holdings in Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company's stock valued at $107,000 after acquiring an additional 2,628 shares during the period. Blue Trust Inc. grew its position in shares of Option Care Health by 16.9% in the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after purchasing an additional 681 shares during the last quarter. Venturi Wealth Management LLC increased its stake in shares of Option Care Health by 2,621.3% in the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock worth $110,000 after purchasing an additional 4,561 shares during the period. Finally, KBC Group NV lifted its position in shares of Option Care Health by 46.4% during the 4th quarter. KBC Group NV now owns 7,337 shares of the company's stock worth $170,000 after purchasing an additional 2,324 shares during the last quarter. Institutional investors own 98.05% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on OPCH shares. JMP Securities reaffirmed a "market outperform" rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and boosted their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. UBS Group assumed coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price target for the company. JPMorgan Chase & Co. boosted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Finally, Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their target price for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $33.00.

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.64% of the company's stock.

Option Care Health Price Performance

NASDAQ OPCH traded down $0.47 on Friday, reaching $34.73. The company's stock had a trading volume of 1,378,809 shares, compared to its average volume of 1,713,822. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a market cap of $5.70 billion, a PE ratio of 29.18, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. The business has a 50-day moving average price of $32.47 and a 200 day moving average price of $28.41.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.